|Articles|January 1, 2010
- BioPharm International-01-01-2010
- Volume 23
- Issue 1
BioPharm International, January 2010 Issue (PDF)
Biopharma Navigates Stormy Seas
Advertisement
Articles in this issue
about 16 years ago
Quality by Design and Compliance Readinessabout 16 years ago
Issues and Opportunities Challenge Biotech Manufacturersabout 16 years ago
Supplier Quality Management: A Risk-Based Approachabout 16 years ago
QbD: A Roadmap to Adoptionabout 16 years ago
Biotech in Good Shape for 2010about 16 years ago
Quality by Design for Biotechnology Products—Part 3about 16 years ago
Can Biopharma Steer Through the Stormy Seas?about 16 years ago
Regulatory Relief: An Idea Whose Time Has ComeNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
2
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
3
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5